<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03338413</url>
  </required_header>
  <id_info>
    <org_study_id>2017/666</org_study_id>
    <nct_id>NCT03338413</nct_id>
  </id_info>
  <brief_title>Cognitive Rehabilitation in Patients With Depression</brief_title>
  <official_title>Cognitive Rehabilitation in Patients With Active and Remitted Depression - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lovisenberg Diakonale Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lovisenberg Diakonale Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Depression is a highly prevalent and debilitating mental disorder, ranked one of the leading
      causes of disability worldwide. Several studies have identified neuropsychological deficits
      in populations of depressed patients affecting domains including attention, memory and
      executive functioning. These deficits often persist even in patients whose depressive
      symptoms have remitted. Cognitive impairment in depression represent a core feature of
      depression, and a valuable target for intervention. Identification of methods that would lead
      to amelioration would be of great clinical interest, and cognitive rehabilitation (CR) could
      be a potential way of achieving this. To date few studies on cognitive rehabilitation in
      depression has been conducted, but the preliminary results are promising. Still the
      demonstration of long-term effects and evidence relating to improved daily life executive
      functioning (i.e., generalization) is lacking. In the present study different group-based
      cognitive rehabilitation interventions will be compared. The aim of the study is to
      investigate if a group-based &quot;brain training&quot; intervention can improve executive function in
      patients with active and remitted depression. Efficacy will be assessed immediately after
      intervention, but also six months after the intervention.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2018</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Behavior Rating Inventory of Executive Function (BRIEF: self and informant form)</measure>
    <time_frame>Change from baseline up to 6 months</time_frame>
    <description>Executive function in daily life (range:70-210). Higher score indicate greater executive dysfunction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance on Conners Continuous Performance test III incl. CATA</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on Wisconsin Card Sorting Test</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on D-KEFS Color Word Interference Test</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on The Emotional Stroop</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on the Emo 1-back task</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Cognitive Failures Questionnaire (CFQ)</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
    <description>Assess frequency of cognitive failures (range:0-100). Higher Score indicate more frequent cognitive failures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Goal Attainment Scaling (GAS)</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Beck Depression Inventory II (BDI-II)</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
    <description>Higher score indicate a higher level of depression (range: 0-63).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM)</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
    <description>Assess the level of current psychological distress (range:0-136). Higher score indicate higher level of distress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on General Perceived Self-Efficacy Scale</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
    <description>Assess a general sense of perceived self-efficacy (range:10-40). Higher score indicate higher self-efficacy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Return to Work Self-Efficacy Scale (RTW-SE)</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
    <description>Assess self-efficacy in the Return to work context (range:0-55). Higher score indicate higher self-efficacy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Difficulties in Emotion Regulation Scale (DERS)</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
    <description>Higher score indicate a higher level of difficulties in emotion regulation (range:36-180).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on The Ruminative Response Scale (RRS)</measure>
    <time_frame>change from baseline up to 6 months</time_frame>
    <description>Higher score indicate a higher level of ruminative responses (range: 22-88).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Goal Management Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Computerized Cognitive Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Goal Management Training</intervention_name>
    <description>9 GMT modules will be administered in 9X2 hour sessions (ten groups). Manualized intervention; metacognitive strategies for improving attention and problem solving.</description>
    <arm_group_label>Goal Management Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Computerized Cognitive Training</intervention_name>
    <description>9 modules will be administered in 9x1 hour session (ten groups). Computerized Cognitive Training using commercially available web-based platforms based on neuroplasticity, developed to target skills such as attention, memory, speed of processing and executive functioning. Homework assignment between sessions.</description>
    <arm_group_label>Computerized Cognitive Training</arm_group_label>
    <other_name>Active control condition</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Completed treatment for mild or moderate MDD

          -  Evidence of executive dysfunction in everyday life determined by (a) a structured
             interview or (b) a self-report Behavior Rating Inventory of Executive Function (BRIEF)
             T-score &lt; 55.

        Exclusion Criteria:

          -  Cognitive, sensory, physical, or language impairment affecting the capacity to
             complete the training program.

          -  Premorbid neurological disease or insult and/or comorbid neurological disorder.

          -  Reported ongoing alcohol or substance abuse.

          -  Psychotic disorders.

          -  Actively suicidal.

          -  Personality disorder sever enough to interfere with the protocol.

          -  Not fluent in Norwegian language.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Joner</last_name>
    <role>Study Director</role>
    <affiliation>Lovisenberg Diaconal Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Stubberud, ph.d</last_name>
    <phone>95104217</phone>
    <email>jan.stubberud@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bj√∏rn Hagen, cand.psychol</last_name>
    <phone>91301061</phone>
    <email>BjornOleIngulfsvann.Hagen@lds.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lovisenberg Diaconal Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2017</study_first_submitted>
  <study_first_submitted_qc>November 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2017</study_first_posted>
  <last_update_submitted>November 13, 2017</last_update_submitted>
  <last_update_submitted_qc>November 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

